Management algorithms for prostate-specific antigen progression in prostate cancer: Biochemical recurrence after definitive therapy and progression to non-metastatic castrate-resistant prostate cancer.
Can Urol Assoc J. 2019 Feb 07;:
Diabetes and kidney cancer survival in patients undergoing nephrectomy: A Canadian multi-center, propensity score analysis.
Urol Oncol. 2019 Jul 05;:
Detection of Relapse by Low-dose Computed Tomography During Surveillance in Stage I Testicular Germ Cell Tumours.
Eur Urol Oncol. 2019 Jul;2(4):437-442
Urol Clin North Am. 2019 Aug;46(3):409-417
Can Urol Assoc J. 2019 Jun;13(6):182-183
Optimal Management of High-risk Stage I Nonseminomatous Germ Cell Tumor: Surveillance is the Preferred Option.
Eur Urol Focus. 2019 May 22;:
Curr Opin Support Palliat Care. 2019 May 10;:
Can Urol Assoc J. 2019 Apr 26;:
Mol Metab. 2019 Apr 10;: